Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Improving kidney function during donor anesthesia

Official title: Renal Graft Functional Enhancement During Donor Anesthesia: A Comparative Study of 3 Modalities

Run by Cairo University · NCT03778944 · Data updated 2026-11-12

This study tests whether giving Mannitol, Dopamine, or extra fluids during anesthesia can help improve kidney function for patients receiving a kidney transplant from a living donor.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment60 (estimated)
SponsorCairo University
Academic / other
Locations1 site (Cairo)
StatusRecruiting
StartedDecember 20, 2018
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedJanuary 12, 2026
Trial IDNCT03778944 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals with end-stage renal disease who are scheduled for living-donor kidney transplantation.

Probably not a fit

Patients with severe cardiac or hepatic dysfunction or coagulopathy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of three different interventions—Mannitol infusion, Dopamine infusion, and adequate hydration—on enhancing the function and perfusion of transplanted kidneys during donor anesthesia. It aims to determine which approach best supports renal graft function in patients undergoing living-donor kidney transplantation. The study focuses on patients with end-stage renal disease and compares the outcomes of the different anesthetic regimens.

Why it matters

Potential benefit: If successful, this study could lead to improved kidney function and outcomes for patients receiving transplants.

How similar studies have gone: While there have been studies focusing on renal graft function, the specific combination of interventions in this study is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* end-stage renal disease, for living-donor kidney transplantation

Exclusion Criteria:

* severe cardiac or hepatic dysfunction
* coagulopathy

Where it's running

  • Kasr Al-Ainy Hospital, Cairo University
    Cairo, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.